bimagrumab semaglutide Weight loss and muscle loss. The facts. GLP-1 drugs like and tirzepatide produce impressive weight loss — but a consistent and underappreciated finding across trials is that a meaningful proportion of Trial suggests GLP-1 combo therapy

L-Carnitine is fairly minor

Safety monitoring is also important, including retinopathy surveillance in high-risk patients, renal function checks if dehydration occurs, and awareness of when to seek urgent care for symptoms of pancreatitis or gallbladder disease

The initial weight loss in the first few weeks is often due to water loss, glycogen (stored carbohydrates), and salt

Mononucleosis (EBV), HIV seroconversion illness, fungal infections in immunocompromised people, thyroiditis, and, rarely, tumors of the throat or voice box can present with a persistent sore throat

Emerging compounds like retatrutide add a third receptor target (glucagon receptor)